Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02213458
Other study ID # 1C12013003302
Secondary ID 5R01AG0567151C1C
Status Completed
Phase N/A
First received
Last updated
Start date March 20, 2015
Est. completion date March 8, 2018

Study information

Verified date February 2024
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized clinical trial evaluating the benefits of a program that supports model care for persons with dementia and their family caregivers. Subjects were recruited from California, Nebraska and Iowa. Subjects determined to be eligible were consented and randomized into one of two groups. Two thirds of patients were enrolled into Navigated Care that provided them with assistance in meeting important benchmarks in their care, for example completion of legal and financial planning and strategies for minimizing caregiver burden. One third of patients were enrolled to a control group, entitled Survey of Care. Outcomes include quality of life, health care utilization, caregiver burden, satisfaction with care, caregiver depression, and caregiver self-efficacy.


Recruitment information / eligibility

Status Completed
Enrollment 1560
Est. completion date March 8, 2018
Est. primary completion date March 8, 2018
Accepts healthy volunteers No
Gender All
Age group 45 Years and older
Eligibility This study will enroll patients as well as their primary caregivers as research participants. Inclusion criteria for patient participants: 1. Patient has a diagnosis of dementia with a progressive course 2. Patient has a primary caregiver (identified as having primary responsibility for patient) that is eligible for and agrees to join the study 3. Patient is covered by Medicare or Medi-caid or is Medi-pending 4. Patient is expected to live at least 3 months based on assessment by the referring provider, the patient's primary care provider, or medical record review 5. Patient speaks either English, Cantonese, Mandarin, or Spanish 6. Patient lives in California or Nebraska or Iowa 7. Patient is age 45 or older Inclusion criteria for caregiver participants: 1. Caregiver has primary responsibility for dementia patient that is eligible for and agrees to join the study 2. Caregiver speaks either English, Cantonese, Mandarin, or Spanish 3. Caregiver is a legal adult Exclusion Criteria: 1. Patient resides in a nursing home or skilled nursing facility at time of enrollment 2. Participant is enrolled in a similar clinical trial that precludes their participation in our trial 3. Patient is pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Navigated Care
Navigated Care emphasizes continuous and personalized care and is based on 3 modules: the Caregiver Module that includes educational interventions and connects families with community resources, the Decision-Making Module that facilitates proactive medical, financial, and safety decisions, and the Medication Module that identifies inappropriate medication usage via pharmacist review. Innovative technology in the form of a "dashboard" functions as a patient care management system used by Care Team Navigators (CTNs).

Locations

Country Name City State
United States University of Nebraska Medical Center Omaha Nebraska
United States University of California, San Francisco San Francisco California

Sponsors (4)

Lead Sponsor Collaborator
University of California, San Francisco Centers for Medicare and Medicaid Services, National Institute on Aging (NIA), University of Nebraska

Country where clinical trial is conducted

United States, 

References & Publications (3)

Guterman EL, Kiekhofer RE, Wood AJ, Allen IE, Kahn JG, Dulaney S, Merrilees JJ, Lee K, Chiong W, Bonasera SJ, Braley TL, Hunt LJ, Harrison KL, Miller BL, Possin KL. Care Ecosystem Collaborative Model and Health Care Costs in Medicare Beneficiaries With De — View Citation

Liu AK, Possin KL, Cook KM, Lynch S, Dulaney S, Merrilees JJ, Braley T, Kiekhofer RE, Bonasera SJ, Allen IE, Chiong W, Clark AM, Feuer J, Ewalt J, Guterman EL, Gearhart R, Miller BL, Lee KP. Effect of collaborative dementia care on potentially inappropria — View Citation

Possin KL, Merrilees JJ, Dulaney S, Bonasera SJ, Chiong W, Lee K, Hooper SM, Allen IE, Braley T, Bernstein A, Rosa TD, Harrison K, Begert-Hellings H, Kornak J, Kahn JG, Naasan G, Lanata S, Clark AM, Chodos A, Gearhart R, Ritchie C, Miller BL. Effect of Co — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life-Alzheimer's Disease, Change From Baseline to 1 Year An established 13-item measure, with a 1-4 ordinal scale for each item, to obtain a rating of the patient's quality of life from the caregiver. Item scores are summed for a total score ranging from 13-52, with higher scores representing better quality of life Baseline to one year
Secondary Change in Caregiver Reported Rate of Emergency Department Utilization: Baseline to One Year Health care utilization based upon caregiver survey to assess emergency department, hospitalization, and ambulance use rates. To be confirmed using Medicare claims data. Baseline to one year
Secondary Change in Caregiver Burden, Baseline to One Year Zarit Burden Interview (short version). An established 12-item measure, with a 0-4 ordinal scale for each item, to measure caregiver burden. Item scores are summed for a total score ranging from 0-48, with higher scores representing higher levels of burden. Baseline to one year
Secondary Satisfaction With Dementia Care A novel 1-item measure, with a 1-5 ordinal scale, to measure caregiver satisfaction with dementia care provided by the patient's clinical team. Also, one question asking caregivers whether they would recommend the Care Ecosystem to another caregiver. Collected in the treatment group only. One year
Secondary Change in Caregiver Depression, Baseline to One Year Patient Health Questionnaire 9 (PHQ-9). Higher scores represent more severe depression. Scores range from 0-27. Baseline to one year
Secondary Change in Caregiver Self-efficacy, Baseline to One Year A novel 4-item measure on a 1-5 ordinal scale to measure self-efficacy around dementia caregiving. Higher scores represent greater self-efficacy. Scores range from 5-15. Baseline to one year
See also
  Status Clinical Trial Phase
Completed NCT04044495 - Sleep, Rhythms and Risk of Alzheimer's Disease N/A
Completed NCT04079803 - PTI-125 for Mild-to-moderate Alzheimer's Disease Patients Phase 2
Terminated NCT03052712 - Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies N/A
Recruiting NCT04520698 - Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease N/A
Active, not recruiting NCT04606420 - Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease N/A
Recruiting NCT05820919 - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase N/A
Terminated NCT03672474 - REGEnLIFE RGn530 - Feasibility Pilot N/A
Completed NCT03430648 - Is Tau Protein Linked to Mobility Function?
Recruiting NCT04949750 - Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease N/A
Recruiting NCT05557409 - A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation Phase 3
Recruiting NCT05288842 - Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Completed NCT06194552 - A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07 Phase 1
Completed NCT03239561 - Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Early Phase 1
Completed NCT03184467 - Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients Phase 2
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Terminated NCT03487380 - Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease N/A
Completed NCT05538455 - Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases N/A
Recruiting NCT05328115 - A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease Phase 1
Completed NCT05562583 - SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support N/A